Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or OfatumumabSven G. Meuth, Steffen Pfeuffer, Thomas Skripuletz et al.|Annals of Neurology|2024Cited by 19
Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With OcrelizumabSteffen Pfeuffer, Sven G. Meuth, Melanie Korsen et al.|Neurology Neuroimmunology & Neuroinflammation|2023Cited by 10